Doherty, NiamhCardwell, Chris RMurchie, PeterHill, ChristopherAzoulay, LaurentHicks, Blánaid2024-11-122024-11-122024-08-15Doherty, N, Cardwell, C R, Murchie, P, Hill, C, Azoulay, L & Hicks, B 2024, 'Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia : A population-based cohort study', International Journal of Cancer, vol. 155, no. 4, pp. 666-674. https://doi.org/10.1002/ijc.349370020-7136ORCID: /0000-0001-9968-5991/work/161796207https://hdl.handle.net/2164/246069793880engSDG 3 - Good Health and Well-beingbenign prostatic hyperplasiacolorectal cancergastro-oesophageal cancer5- alpha reductase inhibitorcancer epidemiologyR MedicineCancer Research UK22185Supplementary Informationhttps://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fijc.34937&file=ijc34937-sup-0001-Tables.pdfRUse of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia : A population-based cohort studyJournal article10.1002/ijc.349371554